gastrointestinal stromal tumors

After a PhIII failure, the FDA delivers Blueprint an expected CRL
Endpoints
Fri, 05/15/20 - 10:37 am
Blueprint Medicines
FDA
complete response letter
Ayvakit
gastrointestinal stromal tumors
Deciphera files for approval of cancer drug ahead of schedule
Fierce Biotech
Mon, 12/16/19 - 10:44 am
Deciphera
ripretinib
gastrointestinal stromal tumors
FDA
Deciphera soars as phase 3 cancer data tee up FDA filing
Fierce Biotech
Tue, 08/13/19 - 10:19 am
Deciphera
clinical trials
ripretinib
gastrointestinal stromal tumors
Bayer's Stivarga endorsed for gastrointestinal stromal tumors
Yahoo/Reuters
Fri, 06/27/14 - 09:43 am
Bayer
Stivarga
gastrointestinal stromal tumors
Europe
ARIAD Announces Initial Data from Phase 2 Trial of Ponatinib in Patients with Gastrointestinal Stromal Tumors
Yahoo/BusinessWire
Sun, 06/1/14 - 11:36 am
Ponatinib
Ariad Pharmaceuticals
gastrointestinal stromal tumors
Threshold Pharmaceuticals Announces Data From Two Ongoing Phase 1/2 Trials of TH-302 at the 2013 ASCO Annual Meeting
Yahoo/MarketWire
Sun, 06/2/13 - 11:39 am
Threshold Pharmaceuticals
TH-302
Multiple Myeloma
gastrointestinal stromal tumors
renal cell carcinoma
kidney cancer
Positive Data on Novartis' Glivec
Yahoo/Zacks
Wed, 04/4/12 - 08:33 am
Novartis
Glivec
gastrointestinal stromal tumors